Degenerative Disease of Lumbar Spine

Clinical Case Study: Addressing Degenerative Disease of the Lumbar Spine with coMra Therapy

This case study follows a patient who presented with severe, searing pain in the lower back. Initially, the discomfort radiated down to both buttocks; however, by the time she sought treatment, the pain had localized to the left buttock, extending down to the middle of her thigh. Her physical mobility was significantly compromised: her body was hunched forward, and she was unable to rest comfortably in bed or even turn over.

The patient’s clinical diagnosis included degenerative spinal disease of the lumbar spine, myotonic syndrome, and radiculopathy. Additionally, she presented with hypertension and irritable bowel syndrome in remission.

The coMra Therapy Treatment Plan

The patient underwent two full courses of coMra therapy, separated by a two-week rest period.

During the first course, the patient received 10 sessions. Due to the intensity of her pain, the treatment protocol was intensified during the first two to three days, with two sessions administered daily. By the third and fourth sessions, the patient reported that her pain began to subside. Consequently, her reliance on painkillers decreased; whereas she had previously required one to two tablets daily, she was able to reduce her intake to a single tablet at night. Following these initial sessions, the patient experienced improved mobility, better sleep quality, and a noticeable improvement in her mood.

By the conclusion of the first course, the patient reported only mild pain in the lumbar region, which occurred primarily during sharp movements. When walking or sitting smoothly, she remained pain-free, and her posture had visibly straightened.

Addressing Severe Degenerative Changes

Given that the patient’s condition was active and an MRI had confirmed severe degenerative changes – including damage to the vertebrae, cartilage structure, and discs, as well as the presence of hernias and protrusions – a second course of coMra therapy was initiated after a two-week break.

During this second course, the patient again received 10 sessions. For the first two days, the frequency was increased to two sessions per day to manage the stress and heightened pain levels the patient was experiencing. As with the first course, the results were significant. By the end of the second course, the patient’s pain had completely resolved, and she regained full, free movement.

Systemic Health Improvements

Beyond the resolution of her spinal symptoms, both the clinical team and the patient observed a stabilization of her blood pressure. Prior to beginning coMra therapy, the patient’s blood pressure consistently measured between 160 and 170, despite her ongoing hypertension medication. By the end of the second course, her blood pressure had stabilized to a range of 120 to 130, while taking only one 2.5 mg tablet of indapamide each morning.

In summary, the two courses of coMra therapy successfully resolved the patient's pain syndrome, restored her sleep, appetite, and range of motion, and provided effective support in stabilizing her secondary condition of hypertension.